OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis Register	116
Activation of circulating monocytes by low-density lipoprotein—a risk factor for osteoarthritis?	86
Enhancing Gout Diagnosis with Deep Learning in Dual-energy Computed Tomography: A Retrospective Analysis of Crystal and Artifact Differentiation	81
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis	78
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply	63
Boxer’s shape, an unusual finding in nailfold capillaroscopy	60
Giant cell arteritis of the prostate	58
Will we ever agree on using low-dose glucocorticoids in treating rheumatoid arthritis?	56
Clinical and serological resolution of pembrolizumab associated Sjögren’s syndrome: long-term follow-up	55
P038 Let’s look at coxitis features in enthesitis-related arthritis population	54
P174 Identifying patterns of fatigue across flares in patients with axial spondyloarthritis	54
E046 Lytic lesions; metastatic disease or gout?	52
P173 The positive utility of PSAID-12 score in remote monitoring and the impact of gender and treatment on patient reported outcomes in psoriatic arthritis	52
P073 Functional investigation of Osteoarthritis-associated non-coding variants using CRISPR/Cas9-mediated perturbation of active enhancer regions	49
P004 Empowering the reproductive choices of patients with rheumatic disease: using the BSR 2022 pregnancy guidelines audit tool to evaluate pre-conception medication advice	48
P025 Risk assessment of covid 19 in patients with Juvenile Idiopathic Arthritis	47
Editor’s Acknowledgement	47
P032 Methotrexate and hepatic tolerance in Juvenile Idiopathic Arthritis	47
Tocilizumab-induced organizing pneumonia in a patient with systemic sclerosis–associated interstitial lung disease	46
P031 Adherence with Methotrexate in Tunisian Juvenile Idiopathic Arthritis Patients	46
P261 Early and accurate diagnosis of patients with axial spondyloarthritis using machine learning: a predictive analysis from electronic health records in the United Kingdom	45
OA04 COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a national cohort	42
P185 Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index	42
P077 Developing a better explanation of osteoarthritis: results from a conjoint analysis of patient preferences	42
Comment on: ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies	42

P179 A feasibility randomised controlled trial of a fibromyalgia self-management programme in a community setting with a nested qualitative study	41
P083 Undergraduate rheumatology teaching in the UK: a survey of teachers	41
P143 Frailty is associated with inflammation, impaired glucose metabolism and reduced bone mineral density after adjustment for fat mass index: a UK biobank study	41
P131 Adult coeliac disease and bone mineral density at the femoral neck, total hip and lumbar spine: an age- and sex-matched case-control study	39
E44 Differences of hematological abnormalities between COVID-19 infection and multisystemic inflammatory syndrome (MIS-C)	38
67 Double impact: hypophosphatemic rickets and vitamin D intoxication	38
Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study	37
Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series	37
Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis	36
Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population	36
Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease	36
Flare of multicentric reticulohistiocytosis in pregnancy	36
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus	36